Nurix Therapeuticsinc Stock Analysis

NRIX Stock  USD 14.54  1.52  11.67%   
Nurix TherapeuticsInc is undervalued with Real Value of 16.78 and Target Price of 26.75. The main objective of Nurix TherapeuticsInc stock analysis is to determine its intrinsic value, which is an estimate of what Nurix TherapeuticsInc is worth, separate from its market price. There are two main types of Nurix TherapeuticsInc's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Nurix TherapeuticsInc's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Nurix TherapeuticsInc's stock to identify patterns and trends that may indicate its future price movements.
The Nurix TherapeuticsInc stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Nurix TherapeuticsInc is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Nurix Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nurix TherapeuticsInc's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.

Nurix Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Nurix TherapeuticsInc was now reported as 4.12. The company recorded a loss per share of 2.65. Nurix TherapeuticsInc had not issued any dividends in recent years. Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company was incorporated in 2009 and is headquartered in San Francisco, California. Nurix Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people. To find out more about Nurix TherapeuticsInc contact the company at 415 660 5320 or learn more at https://www.nurixtx.com.

Nurix TherapeuticsInc Quarterly Total Revenue

15.16 Million

Nurix TherapeuticsInc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nurix TherapeuticsInc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nurix TherapeuticsInc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nurix TherapeuticsInc appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 76.99 M. Net Loss for the year was (143.95 M) with loss before overhead, payroll, taxes, and interest of (145.87 M).
Nurix TherapeuticsInc currently holds about 344.48 M in cash with (81.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.31.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric CancersUsing Targeted Protein Degradation

Nurix TherapeuticsInc Upcoming and Recent Events

Earnings reports are used by Nurix TherapeuticsInc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nurix TherapeuticsInc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024
Upcoming Quarterly Report
View
11th of April 2024
Next Financial Report
View
30th of November 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
31st of August 2023
Last Quarter Report
View
30th of November 2022
Last Financial Announcement
View

Nurix Largest EPS Surprises

Earnings surprises can significantly impact Nurix TherapeuticsInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-07-13
2021-05-31-0.54-0.6-0.0611 
2023-10-12
2023-08-31-0.76-0.680.0810 
2023-02-09
2022-11-30-0.79-0.87-0.0810 
View All Earnings Estimates

Nurix Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nurix TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nurix TherapeuticsInc backward and forwards among themselves. Nurix TherapeuticsInc's institutional investor refers to the entity that pools money to purchase Nurix TherapeuticsInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Dimensional Fund Advisors, Inc.2023-12-31
M
State Street Corporation2023-12-31
921.3 K
Candriam Luxembourg S.c.a.2023-12-31
918.1 K
Pictet Asset Manangement Sa2023-12-31
773.6 K
Tcg Crossover Management, Llc2023-12-31
717.7 K
Affinity Asset Advisors, Llc2023-12-31
690.1 K
Charles Schwab Investment Management Inc2023-12-31
622.3 K
Goldman Sachs Group Inc2023-12-31
563.8 K
Nuveen Asset Management, Llc2023-12-31
533.9 K
Blackrock Inc2023-12-31
4.6 M
Baker Bros Advisors Lp2023-12-31
3.9 M
Note, although Nurix TherapeuticsInc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nurix Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 652.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nurix TherapeuticsInc's market, we take the total number of its shares issued and multiply it by Nurix TherapeuticsInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Nurix Profitablity

Nurix TherapeuticsInc's profitability indicators refer to fundamental financial ratios that showcase Nurix TherapeuticsInc's ability to generate income relative to its revenue or operating costs. If, let's say, Nurix TherapeuticsInc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Nurix TherapeuticsInc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Nurix TherapeuticsInc's profitability requires more research than a typical breakdown of Nurix TherapeuticsInc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.87) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.99) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.99.
Last ReportedProjected for 2024
Return On Capital Employed(0.50)(0.53)
Return On Assets(0.45)(0.48)
Return On Equity(0.83)(0.78)

Management Efficiency

Nurix TherapeuticsInc has return on total asset (ROA) of (0.251) % which means that it has lost $0.251 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.571) %, meaning that it created substantial loss on money invested by shareholders. Nurix TherapeuticsInc's management efficiency ratios could be used to measure how well Nurix TherapeuticsInc manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.53 in 2024. Return On Assets is likely to drop to -0.48 in 2024. At this time, Nurix TherapeuticsInc's Non Current Assets Total are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.35 in 2024, whereas Total Assets are likely to drop slightly above 319.7 M in 2024.
Last ReportedProjected for 2024
Price Book Value Ratio 1.52  1.59 
Enterprise Value Multiple(2.00)(2.10)
Price Fair Value 1.52  1.59 
The analysis of Nurix TherapeuticsInc's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Nurix TherapeuticsInc's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Nurix Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
2.038

Technical Drivers

As of the 28th of March, Nurix TherapeuticsInc secures the Mean Deviation of 3.57, risk adjusted performance of 0.1029, and Downside Deviation of 3.86. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nurix TherapeuticsInc, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Nurix TherapeuticsInc, which can be compared to its peers in the industry. Please verify Nurix TherapeuticsInc information ratio and downside variance to decide if Nurix TherapeuticsInc is priced some-what accurately, providing market reflects its recent price of 14.54 per share. Given that Nurix TherapeuticsInc has jensen alpha of 0.296, we recommend you to check Nurix TherapeuticsInc's last-minute market performance to make sure the company can sustain itself at a future point.

Nurix TherapeuticsInc Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nurix TherapeuticsInc middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nurix TherapeuticsInc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Nurix TherapeuticsInc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nurix TherapeuticsInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nurix TherapeuticsInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nurix TherapeuticsInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nurix TherapeuticsInc Predictive Daily Indicators

Nurix TherapeuticsInc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nurix TherapeuticsInc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Nurix TherapeuticsInc Corporate Filings

27th of March 2024
Other Reports
ViewVerify
8K
11th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
16th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
15th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of February 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
13th of February 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
9th of February 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F4
30th of January 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Nurix TherapeuticsInc Forecast Models

Nurix TherapeuticsInc's time-series forecasting models are one of many Nurix TherapeuticsInc's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nurix TherapeuticsInc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Nurix Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nurix TherapeuticsInc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nurix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nurix TherapeuticsInc. By using and applying Nurix Stock analysis, traders can create a robust methodology for identifying Nurix entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin(2.15)(2.26)
Operating Profit Margin(2.32)(2.43)
Net Loss(2.15)(2.26)
Gross Profit Margin 0.74  0.78 

Current Nurix Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nurix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nurix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
26.75Strong Buy10Odds
Nurix TherapeuticsInc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Nurix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nurix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nurix TherapeuticsInc, talking to its executives and customers, or listening to Nurix conference calls.
Nurix Analyst Advice Details

Nurix Stock Analysis Indicators

Nurix TherapeuticsInc stock analysis indicators help investors evaluate how Nurix TherapeuticsInc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nurix TherapeuticsInc shares will generate the highest return on investment. By understating and applying Nurix TherapeuticsInc stock analysis, traders can identify Nurix TherapeuticsInc position entry and exit signals to maximize returns.
Begin Period Cash Flow64.5 M
Common Stock Shares Outstanding54.3 M
Total Stockholder Equity200.5 M
Property Plant And Equipment Net48 M
Cash And Short Term Investments287.9 M
Cash54.6 M
Accounts Payable6.4 M
Net Debt-24 M
50 Day M A10.7792
Total Current Liabilities87 M
Other Operating Expenses232.1 M
Non Current Assets Total69 M
Non Currrent Assets Other3.8 M
Stock Based Compensation33.7 M
When determining whether Nurix TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nurix TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nurix Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nurix Therapeuticsinc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.
You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Nurix Stock analysis

When running Nurix TherapeuticsInc's price analysis, check to measure Nurix TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix TherapeuticsInc is operating at the current time. Most of Nurix TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Nurix TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix TherapeuticsInc's price. Additionally, you may evaluate how the addition of Nurix TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Directory
Find actively traded commodities issued by global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Nurix TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix TherapeuticsInc. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.65)
Revenue Per Share
1.417
Quarterly Revenue Growth
1.235
Return On Assets
(0.25)
Return On Equity
(0.57)
The market value of Nurix TherapeuticsInc is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Nurix TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix TherapeuticsInc's market value can be influenced by many factors that don't directly affect Nurix TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nurix TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.